Derby Theatre gala to raise funds for artistic director’s cancer treatment
Derby Theatre is hosting a gala night to raise vital funds towards cancer treatment for its artistic director Sarah Brigham.
Brigham, who is also chief executive at the theatre, was diagnosed with a rare form of cancer after a tumour was found in her trachea.
Due to the size and location of the tumour, surgery is not an option and this particular cancer does not respond to chemotherapy.
Brigham is aiming to raise £60,000 for a treatment in Germany, an intense form of radiotherapy, which is unavailable on the NHS.
A crowdfunding page set up by friends and colleagues on Just Giving has already raised more than £47,000.
The Brig-Aid Fundraising Gala Event will be an evening of music and entertainment on May 27, with more details of the line-up to be announced soon.
Brigham said: “In terms of my diagnosis, on the positive side (there has to be one right) I physically feel ok and I remain positive.
“If you see me, you wouldn’t know I have this six centimetre tumour in my windpipe. I’m still working, still laughing and still putting the world to rights, so cancer is not winning.”
She added: “I cannot begin to put into words the overwhelming amount of support I have received from my family, friends, colleagues, businesses, plus hundreds and hundreds of people from across the UK. The amount of donations raised so far is absolutely incredible.
“I will never forget this spirit of generosity and kindness and I thank everyone from the bottom of my heart.”
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.